Among the genetic alterations, the diagnostic and prognostic value of BRAFV600E mutation and TERT promoter mutations have been well studied in PTC and other thyroid malignancies [50,51,52,53,54,55,56,57,58]. The gene discussed is TERT; the disease is thyroiditis.